Candel Therapeutics, Inc.(CADL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CADL Candel Therapeutics, Inc.

盘后交易 07-31 16:01:27 EDT

10.01

+0.14

+1.42%

盘后10.01

+0.000.00%

16:01 EDT

最高10.13	最低9.80	成交量111.55万
今开9.95	昨收9.87	日振幅3.34%
总市值7.33亿	流通市值5.69亿	总股本7,324万
成交额1,114万	换手率1.96%	流通股本5,681万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CADL","market":"US","secType":"STK","nameCN":"Candel Therapeutics, Inc.","latestPrice":10.01,"timestamp":1785528000000,"preClose":9.87,"halted":0,"volume":1115508,"hourTrading":{"tag":"盘后","latestPrice":10.01,"preClose":10.01,"latestTime":"16:01 EDT","volume":13140,"amount":131531.4,"timestamp":1785528077620,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.014184397163120626,"floatShares":56808500,"shares":73244500,"eps":-0.973062,"marketStatus":"盘后交易","change":0.14,"latestTime":"07-31 16:01:27 EDT","open":9.95,"high":10.13,"low":9.8,"amount":11142160.186344,"amplitude":0.033435,"askPrice":10.67,"askSize":9,"bidPrice":9.5,"bidSize":14,"shortable":3,"etf":0,"ttmEps":-0.973062,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1785542400000},"marketStatusCode":4,"adr":0,"listingDate":1627358400000,"exchange":"NASDAQ","adjPreClose":9.87,"preHourTrading":{"tag":"盘前","latestPrice":9.87,"preClose":9.87,"latestTime":"09:25 EDT","volume":345,"amount":3439.95981,"timestamp":1785504300055,"change":0,"changeRate":0,"amplitude":0.099291},"postHourTrading":{"tag":"盘后","latestPrice":10.01,"preClose":10.01,"latestTime":"16:01 EDT","volume":13140,"amount":131531.4,"timestamp":1785528077620,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.889786,"impliedVol":0.4104,"impliedVolPercentile":0.0916},"requestUrl":"/m/hq/s/CADL","defaultTab":"news","newsList":[{"id":"1136258323","title":"Candel Therapeutics宣布根据纳斯达克上市规则5635(c)(4)授予激励股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1136258323","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136258323?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:44","pubTimestamp":1783413881,"startTime":"0","endTime":"0","summary":"Candel Therapeutics, Inc. (CADL)于7月1日宣布，公司已依据纳斯达克上市规则5635(c)(4)的相关条款，向新入职员工授予了激励性股权。此项举措旨在吸引并留住关键人才，同时将员工的利益与公司的长期发展目标紧密结合。根据该规则，此类激励授予通常面向新聘人员，且需经公司董事会或其薪酬委员会的批准。通过股权激励计划，Candel Therapeutics致力于构建一支与公司共同成长的核心团队，为未来的研发与商业化进程注入持续动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CADL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123511344","title":"Candel Therapeutics启动针对免疫检查点抑制剂反应不佳的晚期非小细胞肺癌患者的全球关键Aurora三期试验，评估Aglatimagene Besadenovec (CAN-2409)疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1123511344","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123511344?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:05","pubTimestamp":1782821131,"startTime":"0","endTime":"0","summary":"Candel Therapeutics 已启动一项名为Aurora的全球关键性三期临床试验，旨在评估Aglatimagene Besadenovec（CAN-2409）在那些对免疫检查点抑制剂反应不佳的晚期非小细胞肺癌患者中的疗效。该试验标志着公司候选药物开发进程中的一个重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198482140","title":"Candel Therapeutics 公布局部前列腺癌药物 Aglatimagene Besadenovec (Can-2409) 三期试验长期随访数据，显示多临床终点持续获益","url":"https://stock-news.laohu8.com/highlight/detail?id=1198482140","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198482140?lang=zh_cn&edition=full","pubTime":"2026-05-16 04:06","pubTimestamp":1778875578,"startTime":"0","endTime":"0","summary":"在2026年美国泌尿外科协会年会上，Candel Therapeutics 公布了其针对局部前列腺癌的候选药物 Aglatimagene Besadenovec (Can-2409) 三期临床试验的长期随访数据。数据显示，经过延长随访期，该疗法在多个关键临床终点上持续为患者带来显著的临床获益。\n此次公布的数据进一步证实了 Can-2409 在治疗局部前列腺癌患者中的持久疗效与安全性。长期跟踪结果凸显了该疗法在延缓疾病进展、改善患者生活质量等核心指标上的积极作用，为这一创新疗法的潜在价值提供了有力支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135176107","title":"Candel Therapeutics发布2025年第四季度及全年财报与近期业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1135176107","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135176107?lang=zh_cn&edition=full","pubTime":"2026-03-12 20:07","pubTimestamp":1773317273,"startTime":"0","endTime":"0","summary":"Candel Therapeutics, Inc.公布了2025财年第四季度及全年的财务业绩，同时分享了公司近期的战略动态。报告显示，公司在关键业务领域取得显著进展，并持续推动创新疗法的研发进程。财务数据反映了企业在优化运营效率与扩大临床管线方面的投入成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151526484","title":"Candel Therapeutics 第四季度运营亏损达1575万美元，远超IBES预估的1390万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1151526484","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151526484?lang=zh_cn&edition=full","pubTime":"2026-03-12 20:06","pubTimestamp":1773317173,"startTime":"0","endTime":"0","summary":"Candel Therapeutics公司最新财报显示，其第四季度运营亏损为1575.2万美元，这一数字显著高于IBES分析师普遍预测的1390万美元亏损。实际业绩与市场预期存在明显差距，反映出公司当期运营表现未达市场共识。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CADL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172608055","title":"Candel Therapeutics公布公开募股价：每股5.45美元发行1834.86万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1172608055","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172608055?lang=zh_cn&edition=full","pubTime":"2026-02-20 10:54","pubTimestamp":1771556068,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Inc（纳斯达克：CADL）宣布其公开募股定价细节。该公司将以每股5.45美元的价格发行18,348,624股普通股。此次募股预计将为这家临床阶段生物技术公司注入新的资金流。\n定价决策基于当前市场条件与投资者需求。每股5.45美元的定价反映了资本市场对Candel Therapeutics研发管线的估值预期。此次发行规模与定价的组合，将直接影响公司市值与股权结构。\n（注：文中时间信息存在逻辑矛盾，原始数据提及2026年2月20日的时间戳与事件发布日不匹配，故对时间表述进行技术性处理。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155521852","title":"Candel Therapeutics与Rtw达成协议：后者将获美国Aglatimagene年净销售额分层个位数百分比分成，设上限","url":"https://stock-news.laohu8.com/highlight/detail?id=1155521852","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155521852?lang=zh_cn&edition=full","pubTime":"2026-02-20 05:03","pubTimestamp":1771535028,"startTime":"0","endTime":"0","summary":"根据双方协议，Rtw将有权获得Candel Therapeutics, Inc.旗下产品Aglatimagene在美国市场的年度净销售额的分层个位数百分比作为分成，但此项分成设有上限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125258398","title":"Candel Therapeutics与RTW签署1亿美元特许权融资协议，助力前列腺癌疗法Aglatimagene Besadenovec（CAN-2409）商业化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1125258398","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125258398?lang=zh_cn&edition=full","pubTime":"2026-02-20 05:02","pubTimestamp":1771534955,"startTime":"0","endTime":"0","summary":"Candel Therapeutics近日宣布与生物医药投资机构RTW达成一项规模达1亿美元的特许权融资协议。该资金将专项用于支持其核心候选药物Aglatigmatene Besadenovec在局限性前列腺癌领域的潜在商业化推进。此次合作通过未来药物销售的特许权收益作为融资对价，在降低股权稀释风险的同时，为CAN-2409的临床开发及市场准入提供关键资金支持。此次融资协议的落地，标志着该疗法向商业化阶段迈出关键一步，也为晚期前列腺癌患者提供了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CADL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516460823","title":"Candel Therapeutics, Inc.盘中异动 快速跳水5.06%报7.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516460823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516460823?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:57","pubTimestamp":1741100277,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时57分，Candel Therapeutics, Inc.股票出现波动，股价快速跳水5.06%。Candel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Candel Therapeutics, Inc.公司简介：Candel Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422575896394ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422575896394ca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","CADL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514382443","title":"Candel Therapeutics, Inc.盘中异动 早盘股价大涨5.14%报8.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514382443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514382443?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:17","pubTimestamp":1740673066,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时17分，Candel Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。截至发稿，该股报8.90美元/股，成交量38.8565万股，换手率0.87%，振幅7.20%。Candel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Candel Therapeutics, Inc.公司简介：Candel Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280017469895260f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280017469895260f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","BK4539","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514586310","title":"加拿大投资银行集团：维持Candel Therapeutics(CADL.US)评级，由买入调整至买入评级, 目标价由20.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514586310","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514586310?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:14","pubTimestamp":1740590052,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Candel Therapeutics(CADL.US)评级，由买入调整至买入评级, 目标价由20.00美元调整至25.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27011448413920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CADL","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513398296","title":"Candel Therapeutics, Inc.盘中异动 股价大跌5.28%报11.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513398296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513398296?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148276,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Candel Therapeutics, Inc.股票出现波动，股价大幅下跌5.28%。Candel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Osr Holdings, Inc.、Nkgen Biotech, Inc.、Acelyrin, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为69.10%、60.32%、17.96%，振幅较大的相关个股有Osr Holdings, Inc.、Gain Therapeutics, Inc.、Windtree Therapeutics, Inc.，振幅分别为14.17%、10.21%、7.71%。Candel Therapeutics, Inc.公司简介：Candel Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223116abd7af50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223116abd7af50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","BK4539","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512448497","title":"Candel Therapeutics(CADL.US)获花旗首次覆盖，给予买入评级, 目标价25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512448497","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512448497?lang=zh_cn&edition=full","pubTime":"2025-02-20 19:10","pubTimestamp":1740049838,"startTime":"0","endTime":"0","summary":"Candel Therapeutics(CADL.US)获花旗首次覆盖，给予买入评级, 目标价25.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/20191048285026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CADL","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512488088","title":"Candel Therapeutics, Inc.盘中异动 早盘快速拉升5.36%报10.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512488088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512488088?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:42","pubTimestamp":1739976126,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时42分，Candel Therapeutics, Inc.股票出现异动，股价急速上涨5.36%。Candel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为297.03%、214.17%、67.66%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Allogene Therapeutics, Inc.、Omega Therapeutics, Inc.，振幅分别为207.68%、36.97%、20.84%。Candel Therapeutics, Inc.公司简介：Candel Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224206988b3374&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224206988b3374&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","BK4539","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512177950","title":"Candel Therapeutics(CADL.US)获加拿大投资银行集团首次覆盖，给予买入评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512177950","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512177950?lang=zh_cn&edition=full","pubTime":"2025-02-19 18:42","pubTimestamp":1739961736,"startTime":"0","endTime":"0","summary":"Candel Therapeutics(CADL.US)获加拿大投资银行集团首次覆盖，给予买入评级, 目标价20.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19184248263432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CADL","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512323165","title":"Candel Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报9.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512323165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512323165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:30","pubTimestamp":1739889054,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时30分，Candel Therapeutics, Inc.股票出现异动，股价急速上涨5.08%。截至发稿，该股报9.51美元/股，成交量7.9079万股，换手率0.18%，振幅0.00%。Candel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Candel Therapeutics, Inc.公司简介：Candel Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223054abd3aebc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223054abd3aebc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CADL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509574462","title":"Candel Therapeutics, Inc.盘中异动 早盘股价大涨8.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509574462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509574462?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:31","pubTimestamp":1738938713,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时31分，Candel Therapeutics, Inc.股票出现波动，股价急速上涨8.08%。Candel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Conduit Pharmaceuticals Inc.、Engene Holdings Inc C/Wts 31/10/2028  Cl A、Nutriband Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为1050.29%、39.51%、33.36%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Nutriband Inc.、Renovorx, Inc.，振幅分别为30.97%、13.78%、10.27%。Candel Therapeutics, Inc.公司简介：Candel Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223153a23d2348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223153a23d2348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","CADL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509657754","title":"Candel Therapeutics, Inc.盘中异动 急速拉升5.45%报7.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509657754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509657754?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:49","pubTimestamp":1738684174,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时49分，Candel Therapeutics, Inc.股票出现异动，股价快速拉升5.45%。Candel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1567.44%、906.35%、228.59%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Viracta Therapeutics, Inc.，振幅分别为66.50%、49.88%、44.22%。Candel Therapeutics, Inc.公司简介：Candel Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204234934a239383f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204234934a239383f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","CADL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506468585","title":"Candel Therapeutics, Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506468585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506468585?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:22","pubTimestamp":1738002153,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时22分，Candel Therapeutics, Inc.股票出现异动，股价急速下跌5.01%。Candel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2148.78%、994.74%、256.30%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.60%、99.77%、65.16%。Candel Therapeutics, Inc.公司简介：Candel Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280222349874d26d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280222349874d26d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","BK4539","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504467164","title":"Candel Therapeutics, Inc.盘中异动 急速跳水5.01%报7.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504467164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504467164?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:37","pubTimestamp":1737124623,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时37分，Candel Therapeutics, Inc.股票出现波动，股价急速跳水5.01%。Candel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Revolution Medicines Inc C/Wts 17/12/2026 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Aditxt, Inc.、Aeon Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为101.41%、15.66%、8.61%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为44.21%、31.14%、25.64%。Candel Therapeutics, Inc.公司简介：Candel Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223703986a1650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223703986a1650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","CADL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.candeltx.com","stockEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":-0.0417},{"period":"3month","weight":0.5255},{"period":"6month","weight":0.6901},{"period":"1year","weight":0.5023},{"period":"ytd","weight":0.7469}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0292},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.169},{"period":"ytd","weight":0.0876}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Candel Therapeutics, Inc.于2003年6月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发旨在诱导全身性抗肿瘤免疫反应的现成病毒免疫疗法。其主要候选药物aglatimagene besadenovec是一种基于腺病毒的疗法，正在多种实体瘤适应症中进行研究。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.056687},{"month":2,"riseRate":0.4,"avgChangeRate":0.052018},{"month":3,"riseRate":0.2,"avgChangeRate":-0.120448},{"month":4,"riseRate":0.4,"avgChangeRate":0.650234},{"month":5,"riseRate":1,"avgChangeRate":0.18781},{"month":6,"riseRate":0.2,"avgChangeRate":-0.088023},{"month":7,"riseRate":0.2,"avgChangeRate":0.00047},{"month":8,"riseRate":0.8,"avgChangeRate":0.068985},{"month":9,"riseRate":0.4,"avgChangeRate":-0.01705},{"month":10,"riseRate":0.4,"avgChangeRate":-0.110246},{"month":11,"riseRate":0,"avgChangeRate":-0.079739},{"month":12,"riseRate":0.8,"avgChangeRate":0.288433}],"exchange":"NASDAQ","name":"Candel Therapeutics, Inc.","nameEN":"Candel Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Candel Therapeutics, Inc.(CADL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Candel Therapeutics, Inc.(CADL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Candel Therapeutics, Inc.,CADL,Candel Therapeutics, Inc.股票,Candel Therapeutics, Inc.股票老虎,Candel Therapeutics, Inc.股票老虎国际,Candel Therapeutics, Inc.行情,Candel Therapeutics, Inc.股票行情,Candel Therapeutics, Inc.股价,Candel Therapeutics, Inc.股市,Candel Therapeutics, Inc.股票价格,Candel Therapeutics, Inc.股票交易,Candel Therapeutics, Inc.股票购买,Candel Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Candel Therapeutics, Inc.(CADL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Candel Therapeutics, Inc.(CADL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}